Global Approaches to the Management of Relapsing Multiple Sclerosis

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Latest News

Aerobic Exercise for MS Positively Affects Motor-related Tract and Nuclei Microstructural Integrity

Assessing Lecanemab’s Effect in Early Alzheimer Disease: Sharon Cohen, MD, FRCPC

Tollgate-Related Prognostic Factors Have Stronger Effect on ALS Progression Timing Through Disease Tollgates

Ofatumumab Outperforms Teriflunomide in Newly Diagnosed, Treatment-Naïve Multiple Sclerosis

View More News

Global Approaches to the Management of Relapsing Multiple Sclerosis

EP. 1: Diagnosis of Multiple Sclerosis: The McDonald Criteria

EP. 2: Differential Diagnosis of Multiple Sclerosis

EP. 3: MOG-IgG in Multiple Sclerosis

EP. 4: Clinically Isolated Syndrome Versus Multiple Sclerosis

EP. 5: First-Line Therapies for Relapsing Multiple Sclerosis

EP. 6: The Use of Interferon in Multiple Sclerosis

EP. 7: The Use of Glatiramer Acetate in Multiple Sclerosis

EP. 8: Clinical Trials for Cladribine in Multiple Sclerosis

EP. 9: Treating With Cladribine in Multiple Sclerosis

EP. 10: Role of Siponimod in Multiple Sclerosis

Latest News